By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • The Wire
  • Health Topics
  • Podcast & Media
  • GMJ Articles
  • Perspectives
  • Policy & Systems
  • Dictionary
  • Practice
  • Research Digest
  • Read the Journal →
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Follow US
GMJ News > GMJ Briefs > Alcohol Reduces Protective Gut Immune Structures by Up to 75 Percent

Alcohol Reduces Protective Gut Immune Structures by Up to 75 Percent

GMJ
Last updated: 07/06/2026 16:11
By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Share
1 Min Read
Scientific illustration showing gut-liver pathway disruption by alcohol consumption
New research published in Nature reveals how chronic alcohol consumption disables gut immune defenses, allowing bacteria to invade the liver and worsen damage. The study identifies potential new therapeutic targets for alcohol-associated liver disease. — Photo: Kate Trifo / Pexels
SHARE
1 min read|144 words

A striking new finding from Nature demonstrates the dramatic impact of chronic alcohol consumption on intestinal immune defenses. The research shows that alcohol reduces the formation of goblet cell-associated antigen passages (GAPs) by approximately 75 percent, plummeting from normal levels of 85 percent formation down to just 25 percent in chronic alcohol users.

GAPs serve as critical immune surveillance centers where specialized immune cells learn to recognize and respond to gut bacteria appropriately. This massive reduction in GAP formation directly correlates with impaired mAChR4 receptor function, which alcohol progressively downregulates in intestinal tissue.

The consequences are severe: without adequate GAPs, pathogenic bacteria bypass normal immune checkpoints and invade the liver, where they compound alcohol’s direct toxic effects. This quantifiable deficit in immune infrastructure provides researchers with measurable targets for therapeutic intervention and suggests that restoring GAP formation could represent a viable treatment strategy for alcohol-associated liver disease.

Was this article helpful?

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze, MD, MPH, PhD
Follow:
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Lemierre’s Syndrome: A Rare but Life-Threatening Complication of Throat Infection

Lemierre's syndrome is a rare but potentially fatal thrombophlebitis of the internal…

Why fructose fails to satisfy hunger like glucose: new neurobiology reveals brain’s sugar selectivity

A 2026 study reveals that glucose and fructose activate different hunger-control pathways…

655 Million Without Electricity Face Growing Health Crisis, WHO Warns

The WHO reports that 655 million people lack electricity access and two…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

South Africa’s SAHPRA Issues Recall of Citro-Soda Regular Batches Due to Contamination Risk

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
03/06/2026
Portrait of Eric Edwards, pioneering British urologist and kidney transplant surgeon

Landmark Achievement: The First UK Cadaver Kidney Transplant

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
26/06/2026
WHO Essential Medicines List timeline 1977-2025 showing continuity in core medications

Takeaway: Forty-eight years of WHO essential medicines: core drugs unchanged since 1977

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
31/08/2026
Pharmaceutical industry analysis of obesity drug development and FDA approval mechanisms

Takeaway: Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
20/09/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Accreditation Canada in Georgia
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?